375 related articles for article (PubMed ID: 27114608)
1. Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo.
Liu Y; Tan S; Huang L; Abramovitch RB; Rohde KH; Zimmerman MD; Chen C; Dartois V; VanderVen BC; Russell DG
J Exp Med; 2016 May; 213(5):809-25. PubMed ID: 27114608
[TBL] [Abstract][Full Text] [Related]
2. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection.
Sukumar N; Tan S; Aldridge BB; Russell DG
PLoS Pathog; 2014 Sep; 10(9):e1004394. PubMed ID: 25233380
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.
Subbian S; Tsenova L; O'Brien P; Yang G; Koo MS; Peixoto B; Fallows D; Dartois V; Muller G; Kaplan G
PLoS Pathog; 2011 Sep; 7(9):e1002262. PubMed ID: 21949656
[TBL] [Abstract][Full Text] [Related]
4. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
5. Biofilm formation in the lung contributes to virulence and drug tolerance of Mycobacterium tuberculosis.
Chakraborty P; Bajeli S; Kaushal D; Radotra BD; Kumar A
Nat Commun; 2021 Mar; 12(1):1606. PubMed ID: 33707445
[TBL] [Abstract][Full Text] [Related]
6. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
Kahnert A; Seiler P; Stein M; Bandermann S; Hahnke K; Mollenkopf H; Kaufmann SH
Eur J Immunol; 2006 Mar; 36(3):631-47. PubMed ID: 16479545
[TBL] [Abstract][Full Text] [Related]
7. Inhalable microparticles modify cytokine secretion by lung macrophages of infected mice.
Sharma R; Yadav AB; Muttil P; Kajal H; Misra A
Tuberculosis (Edinb); 2011 Jan; 91(1):107-10. PubMed ID: 21159559
[TBL] [Abstract][Full Text] [Related]
8. Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action.
Kim JJ; Lee HM; Shin DM; Kim W; Yuk JM; Jin HS; Lee SH; Cha GH; Kim JM; Lee ZW; Shin SJ; Yoo H; Park YK; Park JB; Chung J; Yoshimori T; Jo EK
Cell Host Microbe; 2012 May; 11(5):457-68. PubMed ID: 22607799
[TBL] [Abstract][Full Text] [Related]
9. Chemokines in tuberculosis: the good, the bad and the ugly.
Monin L; Khader SA
Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
[TBL] [Abstract][Full Text] [Related]
10. Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.
Iacobino A; Giannoni F; Fattorini L; Brucoli F
J Antibiot (Tokyo); 2018 Sep; 71(9):831-834. PubMed ID: 29795520
[TBL] [Abstract][Full Text] [Related]
11. Differential drug susceptibility of intracellular and extracellular tuberculosis, and the impact of P-glycoprotein.
Hartkoorn RC; Chandler B; Owen A; Ward SA; Bertel Squire S; Back DJ; Khoo SH
Tuberculosis (Edinb); 2007 May; 87(3):248-55. PubMed ID: 17258938
[TBL] [Abstract][Full Text] [Related]
12. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.
Gupta AK; Katoch VM; Chauhan DS; Sharma R; Singh M; Venkatesan K; Sharma VD
Microb Drug Resist; 2010 Mar; 16(1):21-8. PubMed ID: 20001742
[TBL] [Abstract][Full Text] [Related]
13. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
14. TB drug development: immunology at the table.
Nathan C; Barry CE
Immunol Rev; 2015 Mar; 264(1):308-18. PubMed ID: 25703568
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial resistance in tuberculosis].
Gutiérrez-Aroca JB; Ruiz P; Casal M
Rev Esp Quimioter; 2013 Dec; 26(4):332-6. PubMed ID: 24399346
[TBL] [Abstract][Full Text] [Related]
16. Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis.
Nandakumar M; Nathan C; Rhee KY
Nat Commun; 2014 Jun; 5():4306. PubMed ID: 24978671
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.
de Knegt GJ; ten Kate MT; van Soolingen D; Aarnoutse R; Boeree MJ; Bakker-Woudenberg IA; de Steenwinkel JE
Tuberculosis (Edinb); 2014 Dec; 94(6):701-7. PubMed ID: 25621361
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence Setting.
Strydom K; Ismail F; Matabane MM; Onwuegbuna O; Omar SV; Ismail N
J Clin Microbiol; 2015 Sep; 53(9):3032-4. PubMed ID: 26135869
[TBL] [Abstract][Full Text] [Related]
19. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
Shenai S; Rodrigues C; Mehta A
Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
